2024-511254-51-00招募中1 期
Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Eyed Pharma
- 入组人数
- 18
- 试验地点
- 6
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Regulatory
Scientific
Eyed Pharma
研究点 (6)
Loading locations...
相似试验
招募中
1 期
Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients with Parkinson's Disease(ROCK-PD)Idiopathic Parkinson´s DiseaseMedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2021-003879-34-DEKlinikum rechts der Isar der Technischen Universität München75
已完成
1 期
Evaluation of the Safety and Tolerability of the ‘LeVe CPAP Flow Generator’ in Healthy Volunteers at Mengo Hospital in Kampala UgandaRespiratoryPACTR202105734146484Mengo Hospital20
已完成
不适用
Evaluation of the safety and tolerability of the primary posterior capsulotomy during femtosecond laser-assisted cataract surgeryH26.9H26.4Cataract, unspecifiedAfter-cataractDRKS00010845niversitätsklinikum Knappschaftskrankenhaus Bochum GmbH Augenklinik41
已完成
1 期
Evaluation of the safety and feasibility of intra ovarian injection of menstrual blood derived stem cells (MenSCs) in women with poor ovarian response.IRCT20180619040147N2Iranian Academic Center for Education Culture and Research36
撤回
1 期
Safety and tolerability of the Traditional Chinese Medicine Formulation GOPAC in patients with advanced malignancyAdvanced malignancy (palliative)Cancer - Other cancer typesACTRN12609000652279Sydney South West Area Health Service70